# Evaluation of a Specific Transdermal Cannabidiol Product for Chronic Musculoskeletal Joint Pain.

> **NCT05002114** · PHASE1 · WITHDRAWN · sponsor: **Louisiana State University Health Sciences Center Shreveport**

## Conditions studied

- Musculoskeletal Joint Pain

## Interventions

- **DRUG:** Cannabidiol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05002114
- **Lead sponsor:** Louisiana State University Health Sciences Center Shreveport
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-01
- **Primary completion:** 2023-01
- **Final completion:** 2023-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** there were issues with the primary study material that prohibited continuation at this time
- **Last updated:** 2022-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05002114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05002114, "Evaluation of a Specific Transdermal Cannabidiol Product for Chronic Musculoskeletal Joint Pain.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05002114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*